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Research Article
Which sample type is better for Xpert MTB/RIF to
diagnose adult and pediatric pulmonary
tuberculosis?
Mengyuan Lyu1,2,*, Jian Zhou2,*, Yuhui Cheng2, Weelic Chong3, Kang Wu2, Teng Fang2, Tianbo Fu2 and
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Objective: This review aimed to identify proper respiratory-related sample types for adult
and pediatric pulmonary tuberculosis (PTB), respectively, by comparing performance of
Xpert MTB/RIF when using bronchoalveolar lavage (BAL), induced sputum (IS), expecto-
rated sputum (ES), nasopharyngeal aspirates (NPAs), and gastric aspiration (GA) as sample.
Methods: Articles were searched in Web of Science, PubMed, and Ovid from inception
up to 29 June 2020. Pooled sensitivity and specificity were calculated, each with a 95%
confidence interval (CI). Quality assessment and heterogeneity evaluation across included
studies were performed.
Results: A total of 50 articles were included. The respective sensitivity and specificity were
87% (95% CI: 0.84–0.89), 91% (95% CI: 0.90–0.92) and 95% (95% CI: 0.93–0.97) in the
adult BAL group; 90% (95% CI: 0.88–0.91), 98% (95% CI: 0.97–0.98) and 97% (95% CI:
0.95–0.99) in the adult ES group; 86% (95% CI: 0.84–0.89) and 97% (95% CI: 0.96–0.98) in
the adult IS group. Xpert MTB/RIF showed the sensitivity and specificity of 14% (95% CI:
0.10–0.19) and 99% (95% CI: 0.97–1.00) in the pediatric ES group; 80% (95% CI: 0.72–0.87)
and 94% (95% CI: 0.92–0.95) in the pediatric GA group; 67% (95% CI: 0.62–0.72) and 99%
(95% CI: 0.98–0.99) in the pediatric IS group; and 54% (95% CI: 0.43–0.64) and 99% (95%
CI: 0.97–0.99) in the pediatric NPA group. The heterogeneity across included studies was
deemed acceptable.
Conclusion: Considering diagnostic accuracy, cost and sampling process, ES was a better
choice than other sample types for diagnosing adult PTB, especially HIV-associated PTB.
GA might be more suitable than other sample types for diagnosing pediatric PTB. The actual
choice of sample types should also consider the needs of specific situations.
Introduction
Globally, there were 10 million new tuberculosis (TB) cases and 1.24 million deaths in 2018 alone [1].
A body of studies have confirmed that early diagnosis and treatment can prevent most TB deaths [2–4],
and thus excellent diagnostic tools need to be developed. The Xpert MTB/RIF (Cepheid, Sunnyvale, CA,
United States) was endorsed as a diagnostic test for use in TB endemic countries by World Health Or-
ganization (WHO) in 2010 [5]. A systematic review of Xpert MTB/RIF studies has reported different
sensitivities of Xpert MTB/RIF, ranging from 25 to 100% [6]. A study has shown the sensitivity of Xpert
MTB/RIF varies with the sample types, samples quality, and bacterial load of samples [7]. Thus, choosing
proper sample types is critical to improve the diagnostic performance of Xpert MTB/RIF. Given the high
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 1. The flow diagram of articles included in this meta-analysis
prevalence of pulmonary TB (PTB) [8], we paid attention to the selection of respiratory-related sample types to better
diagnose PTB.
The application of urine and stool for diagnosing PTB have been reported [9,10], however, considering high TB
burden areas which are usually economically underdeveloped, high cost of Xpert MTB/RIF and relatively low detec-
tion rate in non-respiratory samples [11], respiratory-related sample become the first choice for detecting Mycobac-
terium tuberculosis (MTB) in clinical practice, at least for now. Expectorated sputum (ES), induced sputum (IS),
bronchoalveolar lavage (BAL) fluid, gastric aspiration (GA), and nasopharyngeal aspirates (NPAs) are considered
suitable samples to detect PTB and are regularly collected in clinical practice. ES is readily available, however, has low
bacterial load. IS, sputum induced by the inhalation of hypertonic saline, usually has large sample volume and higher
quality than ES [12]. BAL has been widely accepted as the most specific sample type used for accurate and timely
diagnosis of lung diseases [13,14]. The WHO supports the collection of BAL to diagnose PTB when possible [15].
However, high cost, invasive sampling and the potential risk of hemorrhage, pneumothorax, laryngospasm and other
2 © 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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adverse reactions limit its application [16]. It is also worth noting that in clinical practice, bronchoscopy and lavage
are not considered as feasible in young children due to the potential risk for anesthesia and need of specialized pro-
cedural expertise, unless otherwise specified [17]. NPA is sampled after stimulation of the cough reflex via inserting
a small feeding catheter into the nasopharynx [18]. Low operational requirements, less invasive sampling, and ready
access enable NPA to become an alternative to BAL for pediatric PTB, but not for adult PTB due to significantly dif-
ferent airway microbial composition between NPA and BAL [17]. Young children, particularly who under 5 years,
are unable to expectorate sputum and always swallow sputum in their stomach by mistake, thus GA is collected by a
nasogastric tube during night in three consecutive mornings to detect MTB for pediatric PTB [19,20]. Nonetheless,
MTB is less likely to be detected in GA than smear in adults, and therefore, and thus GA is not regarded as an option
for detecting MTB for adult PTB [21]. Enough volume and consecutive samples of GA support repeat tests to improve
the rate of detection [22].
Although there are many samples types to choose from, different samples vary greatly in cost, requirement for
operators and operating environment, the degree of sampling invasiveness, quality, volume, and others. It is hard
to assess which is the best choice for diagnosing PTB. In addition, few studies pay attention to assess the impact of
different sample types on the performance of Xpert MTB/RIF when diagnosing PTB. Therefore, we undertook this
systematic review and meta-analysis to compare the detection capacity of Xpert MTB/RIF when using ES, IS, and
BAL as samples for diagnosing adult PTB, as well as ES, IS, GA, and NPA for diagnosing pediatric PTB. We aimed to




We conducted a full search in Web of Science, PubMed, and Ovid on 29 June 2020, with the following terms: ‘tu-
berculosis’, ‘mycobacterium tuberculosis’, ‘TB’, ‘MTB’ AND ‘GeneXpert’, ‘Xpert’, ‘Xpert MTB/RIF’, ‘GX’ AND ‘gas-
tric aspirate’, ‘gastric aspiration’, ‘gastric specimen’, ‘gastric lavage aspiration’, ‘GA’, ‘GLA’, ‘GS’, ‘bronchoalveolar lavage’,
‘bronchoalveolar lavage fluid’, ‘bronchoalveolar washing’, ‘BAL’, ‘BALF’, ‘BW’, ‘induced sputum’, ‘IS’, ‘expectorated spu-
tum’, ‘ES’, ‘nasopharyngeal aspirates’, ‘NPA’. Potential studies were manually identified from reference lists of relevant
articles. Any disagreements would be discussed by two independent authors and, if necessary, a third reviewer would
arbitrate.
Inclusion and exclusion criteria
Included studies needed to: (i) be cross-sectional studies, cohort studies, or randomized controlled trials; (ii) focus
on PTB patients with or without other diseases; (iii) use two diagnostic methods—Xpert MTB/RIF and culture, and
take culture as the reference standard; (iv) collect GA, NPA from children, or BAL from adults, or IS or ES from both;
(v) give clear information that participants were adults or children. Exclusion criteria were: (i) reviews, case reports,
letters, conference abstracts, and animal experiments; (ii) articles not written in English; (iii) articles with incomplete
basic data.
Quality assessment
Two independent reviewers assessed the quality of included studies according to the Revised Tool for Quality As-
sessment of Diagnostic Accuracy Studies (QUADAS)-2 [23]. Both risk of bias and applicability concerns would be
evaluated as ‘high’, ‘unclear’ or ‘low’. Advice of a third reviewer would be referred if necessary.
Data extraction and management
All data were collected and entered into Microsoft Excel version 2016. The basic information mainly comprised
the first author, publication year, study population’s characteristics, and so on. Diagnostic information included
true-positive, false-positive, true-negative, and false-negative. If necessary, we contacted the authors for more es-
sential information, otherwise the trials with incomplete information would be excluded.
Heterogeneity
The threshold effect and non-threshold effect could result in heterogeneity. The heterogeneity caused by the threshold
effect could be explored by performing the Spearman correlation coefficient or plotting summary receiver operating
characteristic curves (sROCs). The threshold effect would exist if P-value of the Spearman correlation coefficient
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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was less than 0.05 or the points in the plots had a curvilinear (shoulder arm) pattern. If Chi-square P-values were less
than 0.10, heterogeneity might be caused by a non-threshold effect and a random-effects model would be chosen.
Sensitivity analysis
Sensitivity analysis was performed to determine the robustness of any treatment effect by removing low-quality stud-
ies.
Statistical analysis
The diagnostic performance of Xpert MTB/RIF was assessed by calculating the pooled sensitivity, specificity, and
area under the curve (AUC), with a 95% confidence interval (CI). The forest plots and sROC were also plotted. We
performed statistical analysis with Meta-DiSc 1.4 (XI Cochrane Colloquium, Barcelona, Spain) and Review Manager
V.5.3 (The Cochrane Collaboration, Software Update, Oxford, U.K.).
Results
Studies’ characteristics
We identified 50 articles: 17 [7,24–39] in the adult BAL group, 14 [35,40–52] in the adult ES group, 7 [35,45,50,53–56]
in the adult IS group, 2 [57,58] in the pediatric ES group, 6 [57,59–63] in the pediatric GA group, and 9 [59,64–71]
in the pediatric IS group from 1791 studies for the meta-analysis. A total of 2864 BAL samples, 18176 ES samples,
and 3876 IS samples were collected from adults. A total of 593 ES samples, 1595 GA samples, 2759 IS samples, and
780 NPA samples were collected from children. More than 80% of all samples were preprocessed, including neutral-
ization, centrifugation, or other processing. The volume of BAL, ES, and IS were 1.0–5 ml, ≥1.0 ml, and 0.5–2.0 ml,
respectively. The volume of GA varied from 0.1 ml to more than 5 ml, while 0.5–1.5 ml IS was collected from children.
The flow diagram of articles included in this meta-analysis is presented in Figure 1. The main characteristics of 43
included articles are summarized in Table 1.
Risk of bias
The risk of bias of the included studies is shown in Table 2.
Among 17 studies in the adult BAL group, 5 articles were assessed as low risk and the rest had an unclear risk on
the patient selection. For the index test, 13 publications had a low risk and 4 publications had an unclear risk. In
the aspect of reference standard and flow and timing, all trials gave clear description about trial details, except for
two [27,29]. A total of 14 studies had low concern for applicability, however, the risk of patient selection of 2 studies
[37,72] were unclear and that of Ullah et al. [38] was high.
For 14 studies in the adult ES group, 10 studies were assessed as low risk on the patient selection, 3/14 were con-
sidered as high risk and the remaining was identified as unclear risk. All of them showed low risk on the index test,
reference standard and flow, and timing. Low concern of patient selection and index test appeared in all 14 publica-
tions. All studies were evaluated as low risk on reference standard except for two [40,51].
For seven studies in the adult IS group, three articles had low risk of patient selection, three articles had unclear
risk of patient selection and only one had high risk of patient selection. Two studies [50,56], which did not state
whether the results from two methods were double-blind, assessed as unclear risk on the index test and reference
standard. Besides, Luetkemeyer et al. [45] also had an unclear risk on reference standard. All articles in this group
were considered as low risk on applicability concerns.
In the pediatric ES group, two studies showed low risk in risk of bias and applicability concerns.
In the pediatric GA group, two articles had low risk of patient selection while others were of unclear risk. Unclear
risk of the index test and reference standard only appeared in one publication. Five trials had low risk of flow and
timing and applicability concerns, and one [62] was evaluated as high risk for patient selection.
In the pediatric IS group, all studies had low risk of patient selection except two [59,68]. Das et al. [59], LaCourse
et al. [64], and Nicol et al. [66] had unclear risk of the index test and reference standard. Five articles had low concern
of applicability, while another two studies [64,69] were assessed as high risk of patient selection.
In the pediatric NPA group, two studies showed low risk of bias and applicability concerns.
Heterogeneity
The value of Spearman correlation coefficient showed that the threshold effects did not exist in the adult BAL
group (Spearman correlation coefficient: 0.158; P=0.727), adult ES group (Spearman correlation coefficient: 0.251;
4 © 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Table 1 The main characteristics of included trials










rate (%) Culture type
Adult BAL1 group
Barnard, 2015 South Africa NA2 112 Decontamination and
centrifugation
15 NA MGIT
Gowda, 2018 India NA 60 Unprocessed 12 7 MGIT
Jo, 2016 South Korea NA 320 Centrifugation 8 0 MGIT and Ogawa
Khalil, 2015 Pakistan NA 93 NA 37 NA LJ3





Ko, 2016 Korea NA 249 NA NA 0 MGIT and Ogawa
Lee, 2013 Korea NA 132 Decontamination and
centrifugation
5 0 MGIT and Ogawa
Lu, 2018 China NA 238 Decontamination 9 NA MGIT and LJ
Mok, 2016 Singapore Inpatients and
outpatients
158 NA 6 NA MGIT
Pan, 2018 China NA 190 Decontamination 19 NA MGIT
Prakash, 2018 Six countries Inpatients and
outpatients
383 NA 6 NA MGIT and LJ
Sánchez-Cabral, 2020 Brazil NA 54 NA NA 41 MGIT and LJ
Sharma, 2015* India NA 131 Decontamination and
centrifugation
NA NA MGIT and LJ
Theron, 2013 South Africa NA 154 Centrifugation 10 30 MGIT
To, 2018 China NA 237 NA NA 2 NA
Ullah, 2017 Pakistan NA 98 Decontamination 0 100 NA
Silva, 2019 Brazil NA 199 NA NA NA MGIT and LJ
Adult ES4 group
Al-Darraji, 2013 Malaysia Prison 125 Decontamination and
centrifugation
NA 100 MGIT
Boum, 2016 Uganda NA 1016 NA 20 66 MGIT
Friedrich, 2011 South Africa NA 292 Decontamination and
centrifugation
97 42 MGIT
Geleta, 2015 Somali NA 227 Decontamination 26 NA MGIT and LJ
LaCourse, 2016 Kenya NA 288 Decontamination NA 100 MGIT
Luetkemeyer, 2016* American, Brazil,
and Rio de Janeiro
Inpatients and
outpatients
992 Unprocessed 15 NA MGIT and solid
media
Madico, 2016 Mbarara and
Uganda
Inpatients 261 Decontamination 15 100 MGIT
Pinyopornpanish, 2015 Thailand NA 57 NA 14 46 MGIT
Rachow, 2011 Tanzania NA 126 Decontamination NA NA MGIT and LJ
Rasheed, 2019 Pakistan NA 225 Unprocessed 0 NA LJ
Rice, 2017* American NA 637 Decontamination and
centrifugation
30 NA MGIT and LJ
Sahle, 2019 Ethiopia Prison 13803 NA 0.1 0.6 MGIT
Sharma, 2015* India NA 71 Decontamination and
centrifugation
NA NA MGIT and LJ
Yeong, 2020 Australia Inpatients 56 Decontamination 11 0 MGIT
Adult IS5 group
Acuna, 2017 Uganda Inpatients and
outpatients
860 Decontamination 89 69 MGIT
Luetkemeyer, 2016* America and Brazil NA 324 NA NA NA MGIT and solid
media
Mishra, 2020 South Africa NA 585 Decontamination 12 20 MGIT and LJ
O’Grady, 2012 Zambia Inpatients 881 Centrifugation 18 71 MGIT
Rice, 2017* America NA 653 Decontamination and
centrifugation
NA NA MGIT and LJ
Sharma, 2015* India NA 71 Decontamination and
centrifugation
NA NA MGIT and LJ
Sohn, 2014 Canada NA 502 Decontamination 3 2 MGIT
Continued over
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Table 1 The main characteristics of included trials (Continued)










rate (%) Culture type
Pediatric ES group
Bates, 2013* Zambia Inpatients 142 Decontamination and
centrifugation
7 31 MGIT
Reither, 2015 Tanzania and
Uganda
NA 451 Decontamination NA 44 MGIT and LJ
Pediatric GA6 group
Bates, 2013* Zambia Inpatients 788 Decontamination and
centrifugation
4 30 MGIT




106 NA NA NA LJ
Hasan, 2017 Pakistan NA 49 Decontamination and
centrifugation
NA NA MGIT
Myo, 2018 Myanmar NA 231 Decontamination and
centrifugation
5 13 LJ
Pang, 2014 China NA 211 Decontamination and
centrifugation
0 NA MGIT
Sharma 2020 India Outpatients 210 Decontamination 7 NA MGIT
Pediatric IS group




8 Nebulization NA NA LJ
LaCourse, 2014 Malawi NA 300 NA 0 17 MGIT
Nicol, 2011 South Africa NA 452 Decontamination and
centrifugation
6 24 MGIT
Nicol, 2013 South Africa NA 115 Decontamination and
centrifugation
3 15 MGIT
Nicol, 2018 South Africa NA 367 Decontamination and
centrifugation
NA 19 MGIT and LJ
Sekadde, 2013 Uganda Mixed 250 Digestion and decontamination 6 42 MGIT and LJ
Togun, 2015 Gambia Outpatients 487 Digestion, decontamination, and
centrifugation
1 0 MGIT and LJ
Zar, 2012* South Africa Inpatients 396 Decontamination and
centrifugation
5 20 MGIT




Zar, 2012* South Africa Inpatients 396 Decontamination and
centrifugation
4 20 MGIT
Zar, 2013* South Africa NA 384 Decontamination and
centrifugation
NA NA MGIT








P=0.387), adult IS group (Spearman correlation coefficient: 0.321; P=0.482), pediatric GA group (Spearman cor-
relation coefficient: −0.257; P=0.623), and pediatric IS group (Spearman correlation coefficient: 0.200; P=0.606).
Besides, the distribution of points in sROC curve also confirmed this. Due to the limited articles in the pediatric ES
group and pediatric NPA group, Spearman correlation coefficient and sROC were unavailable.
The value of Chi-square P-values indicted heterogeneity was caused by non-threshold effects in the adult BAL
group (Chi-square: 42.33; P<0.001), adult ES group (Chi-square: 52.15; P<0.001), adult IS group (Chi-square: 18.95;
P=0.004), pediatric ES group (Chi-square: 13.89; P=0.002) and pediatric GA group (Chi-square: 47.45; P<0.001).
However, non-threshold effects were not detected in the pediatric IS group (Chi-square: 8.40; P=0.396), and pediatric
6 © 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Table 2 The risk of bias of the included studies












Barnard, 2015 unclear unclear low low low low low
Gowda, 2018 unclear low low low low low low
Jo, 2016 unclear low low low unclear low low
Khalil, 2015 unclear unclear unclear unclear low low low
Kilaru, 2019 low low low low low low low
Ko, 2016 unclear unclear unclear unclear low low low
Lee, 2013 unclear low low low low low low
Lu, 2018 low low low low low low low
Mok, 2016 unclear low low low low low low
Pan, 2018 unclear low low low low low low
Prakash, 2018 low low low low low low high
Sánchez-Cabral, 2020 low low low low low low low
Sharma, 2015* low low low low low low low
Silva, 2019 unclear unclear low low low low low
Theron, 2013 unclear low low low low low low
To, 2018 unclear low low low unclear low low
Ullah, 2017 unclear low low low high low low
Adult ES2 group
Al-Darraji, 2013 high low low low low low unclear
Boum, 2016 low low low low low low low
Friedrich, 2011 unclear low low low low low low
Geleta, 2015 low low low low low low low
LaCourse, 2016 high low low low low low low
Luetkemeyer, 2016* low low low low low low low
Madico, 2016 high low low low low low low
Pinyopornpanish, 2015 low low low low low low low
Rachow, 2011 low low low low low low low
Rasheed, 2019 low low low low low low low
Rice, 2017* low low low low low low low
Sahle, 2019 low low low low low low unclear
Sharma, 2015* low low low low low low low
Yeong, 2020 low low low low low low low
Adult IS3 group
Acuna, 2017 high low low low low low low
Luetkemeyer, 2016* unclear low unclear low low low low
Mishra, 2020 low low low low low low low
O’Grady, 2012 unclear low low low low low low
Rice, 2017* unclear unclear unclear low low low low
Sharma, 2015* low low low low low low low
Sohn, 2014 low unclear unclear low low low low
Pediatric ES group
Bates, 2013* low low low low low low low
Reither, 2015 low low low low low low low
Pediatric GA4 group
Bates, 2013* unclear low low low low low low
Das, 2018* unclear unclear unclear low low low low
Hasan, 2017 unclear low low low low low low
Myo, 2018 unclear low low low low low low
Pang, 2014 low low low low high low low
Sharma, 2020 low low low low low low low
Pediatric IS group
Das, 2018* unclear unclear unclear low low low low
Continued over
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Table 2 The risk of bias of the included studies (Continued)











LaCourse, 2014 low unclear unclear low high low low
Nicol, 2011 low low low low low low low
Nicol, 2013 low unclear unclear low low low low
Nicol, 2018 low low unclear low low low low
Sekadde, 2013 high low low low low low low
Togun, 2015 low low low low high low low
Zar, 2012* low low low low low low low
Zar, 2013* low low low low low low low
Pediatric NPA5 group
Zar, 2012* low low low low low low low
Zar, 2013* low low low low low low low






Figure 2. sROC curve for Xpert MTB/RIF of five groups
(A) sROC of adult BAL group; (B) sROC of adult ES group; (C) sROC of adult IS group; (D) sROC of pediatric GA group; (E) sROC
of pediatric IS group.
NPA group (Chi-square: 1.57; P=0.211). The sROC curves for Xpert MTB/RIF of five groups (adult BAL group, adult
ES group, adult IS group, pediatric GA group, and pediatric IS group) are shown in Figure 2.
8 © 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 3. The summary plots of adult PTB
(A) Summary plots of adult BAL group; (B) summary plots of adult ES group; (C) summary plots of adult IS group. Abbreviations:
FN, false-negative; FP, false-positive; TP, true-positive; TN, true-negative.
Results on diagnostic accuracy
The diagnostic performance of Xpert MTB/RIF was calculated, compared with culture. Xpert MTB/RIF showed the
pooled sensitivity, pooled specificity, and AUC were 87% (95% CI: 0.84–0.89), 91% (95% CI: 0.90–0.92) and 95%
(95% CI: 0.93–0.97) in the adult BAL group; 90% (95% CI: 0.88–0.91), 98% (95% CI: 0.97–0.98) and 97% (95% CI:
0.95–0.99) in the adult ES group; 86% (95% CI: 0.84–0.89), 97% (95% CI: 0.96–0.98) and 98% (95% CI: 0.94–0.99) in
the adult IS group; 80% (95% CI: 0.72–0.87), 94% (95% CI: 0.92–0.95) and 95% (95% CI: 0.87–1.00) in the pediatric
GA group; 67% (95% CI: 0.62–0.72), 99% (95% CI: 0.98–0.99) and 97% (95% CI: 0.92–1.00) in the pediatric IS group,
respectively. The pooled sensitivity and pooled specificity were 14% (95% CI: 0.10–0.19) and 99% (95% CI: 0.97–1.00)
in the pediatric ES group and 54% (95% CI: 0.43–0.64) and 99% (95% CI: 0.97–0.99) in the pediatric NPA group,
respectively. Due to the limited articles in the pediatric ES group and pediatric NPA group, the AUC was unavailable.
The summary plots of Xpert MTB/RIF for adult and children are presented in Figures 3 and 4, respectively.
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
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Figure 4. The summary plots of pediatric PTB
(A) Summary plots of pediatric ES group; (B) summary plots of pediatric GA group; summary plots of pediatric IS group; (D) summary
plots of pediatric NPA group. Abbreviations: FN, false-negative; FP, false-positive; TN, true-negative; TP, true-positive.
Subgroup analysis was carried out to determine the potential source of heterogeneity among included articles. The
detailed information is presented in Supplementary Table S1.
Discussion
Since we only included studies using Xpert MTB/RIF, all comparisons made were between the types of biological
samples used. For adults, choosing ES as sample provided better diagnostic performance than BAL or IS. For children,
GA showed superior diagnostic capacity to ES, IS, or NPA. Of note, GA also has its own disadvantages including
invasive sampling and needing approximately three consecutive days for collecting samples. The actual choice needs
to be decided according to specific situations.
It is particularly notorious that microbiology methods (including sputum microscopy and culture), immunolog-
ical methods [interferon-γ release assay (IGRA) and T-cell spot (T-SPOT)] and molecular methods [polymerase
chain reaction (PCR)] are widely applied worldwide before the Xpert MTB/RIF came to market. The celerity and
convenience of sputum microscopy make it the most commonly used method in clinical practice, nonetheless low
sensitivity (20–40%) is the fatal defect of the sputum microscopy [73]. Culture, as the reference standard for the di-
agnosis of TB, requires too long detection time and a highly equipped laboratory. Thus, culture is greatly limited in
some developing regions typically facing a high TB burden. IGRA and T-SPOT are effective ways to screen latent TB
infection. However, inoculating Bacille Calmette–Guérin (BCG), prior infection and inhalation of non-pathogenic
10 © 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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mycobacterium can result in false positivity of IGRA and T-SPOT [74]. Thus, the clinical value of these two diagnos-
tic methods is somewhat discounted in TB endemic areas. Although PCR is a relatively sensitive method to detect
MTB, high requirement of operator skills and a laboratory environment also restrict its application. The emergency
of Xpert MTB/RIF meets the urgent demand for rapid, simple, integrated, and fully automated detective methods of
MTB detection. A myriad of randomized controlled trials (RCTs) have been carried out to assess the diagnostic per-
formance of Xpert MTB/RIF and found the detection rate of MTB is dramatically improved by this novel molecular
tool [75]. Apparent benefit brought by Xpert MTB/RIF to PTB patient individually and public health enables this
molecular tool to be rapidly accepted and applied all over the world.
However, Xpert MTB/RIF still faces some challenges of inadequate sensitivity when diagnosing smear-negative
PTB, pediatric PTB, HIV-associated PTB, and extra-PTB [76,77]. In order to increase diagnostic yield, the Xpert
MTB/RIF Ultra (Ultra; Cepheid) appeared. Based on the same platform as the Xpert MTB/RIF, the Ultra harbors
some improvements including using two PCR amplification targets (IS6110 and IS1081) and a melt curve analysis
[78]. These two changes confer Ultra’s lower limit of detection than Xpert MTB/RIF and culture [78]. The following
clinical trials have found that improper sample types and poor sample quality still have an adverse influence on the
sensitivity of Ultra [79,80]. Obviously, no matter how sensitive the detection method is, choosing proper sample type
and ensuring the quality of sample are crucial.
In our systematic review, choosing ES as sample provided better diagnostic performance (sensitivity, specificity, and
AUC) than BAL or IS for adult PTB. Since both BAL and IS had a higher bacterial load than ES [81,82], they should
theoretically provide better diagnostic performance than ES. However, our study showed opposite results. One reason
is the smaller volume of IS, ranging from 0.5 to 2 ml, whereas the volume of ES ranges from 1 ml to more than 2 ml.
This inconsistency may also be explained by the ratio of processed samples. The ratio of processed samples in the
adult ES group was higher than that in the adult BAL group. In addition, we also found there was a high agreement in
diagnosing adult PTB when using IS and BAL as sample. Considering cost, sampling method, acceptance and other
factors, IS might be a better choice than BAL to diagnose PTB. Blau et al. [83] gave the interpretation of this results
that sampling from one or two parts of lung led to poor repeatability and limited detection rate when taking BAL as
sample to diagnose lung infection diseases. Garcia et al. [84] found the gene transcriptional patterns of MTB in BAL
and sputum were similar, and additionally, sputum could reflect the physiological state of MTB in the lower airway
of PTB patients. Conde et al. [85] conducted a trial and reconfirmed the higher diagnostic yield of taking IS (relative
to BAL) as sample to diagnose PTB, in line with our results.
For pediatric PTB, similar specificity and AUC appeared when using IS and GA as sample, nonetheless, Xpert
MTB/RIF showed much higher sensitivity when using GA as sample to diagnose pediatric PTB. Although GA is
sampled by invasive ways and need approximately three consecutive days for collecting samples, the characteristics
of lower probability of contamination, easy sample collection, and sufficient sample volume still make GA become an
ideal sample type to increase detection rate for pediatric PTB. Ruiz Jimenez et al. [86] may agree with our results that
GA is an excellent sample for diagnosing PTB, and IS should be considered as a supplementary sample type. However,
Zar et al. [87] drew an opposite conclusion by conducting a prospective study, with IS for diagnosing PTB and GA
as supplementary. The differences may result from different diagnostic tools and the variation in sample collection.
The culture, used in their study [87], was unable to detect dead MTB which was caused by the neutralization of GA
[88], while Xpert MTB/RIF used in our included studies can detect both dead and live MTB and is not affected by
sample neutralization. Furthermore, sample collection, technician skill level, the time from sampling to testing and
choice of pre-processing methods also influence finial accuracy [89]. Thus, it is worthy for us to pay attention to the
standardization of GA sampling.
Subgroup analysis showed that for adult PTB, superior diagnostic performance appeared in the smear-positive
subgroup whether using BAL, ES, or IS as samples. Xpert MTB/RIF showed similar sensitivity whether using
smear-positive BAL, smear-positive ES or smear-positive IS, while the highest AUC (90%) was identified when using
BAL to diagnose smear-negative PTB. BAL was sampled directly from the lesion region, which was more suitable
and reliable for detecting PTB patients with low bacterial load [90,91]. In addition, outperformed capacity of Xpert
MTB/RIF appeared when detecting MTB in IS or ES than in BAL for HIV-positive patients. Singer-Leshinsky et al.
[92] obtained consistent results with ours that collecting IS from HIV patients may be more beneficial than others.
Sample pre-procession steps, the number of samples, the immune status of patient, and the degree of disease severity
are the potential confounding factors. More sound evidence is still lacking to support the value of ES in diagnosing
HIV-associated adult PTB, which need to be further confirmed.
For pediatric PTB, we reconfirmed the strong association between smear status, bacterial load, and the diagnostic
performance of Xpert MTB/RIF. Besides, testing for MTB in IS from children provided a little additional diagnostic
yield from the prospective of specificity and AUC for Xpert MTB/RIF when diagnosing smear-negative PTB, however,
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Xpert MTB/RIF had higher likelihood to detect MTB in GA from these smear-negative children who really suffered
from PTB. Maynard-Smith et al. [6] reported that detecting MTB in GA for sputum-scarce PTB was a good choice.
However, Maynard-Smith et al. did not analyze the diagnostic accuracy of Xpert MTB/RIF when detecting MTB
in IS from children and make further comparisons. The diagnostic value of GA and IS for smear-negative PTB for
children still need to be explored. In the pediatric IS group, subgroup analysis showed that the pooled sensitivity was
very heterogeneous between HIV-positive and HIV-negative subgroups and higher sensitivity was in the HIV-positive
subgroup. This result was contrary to Connell et al. [93], however, supported by Nicol et al. [65] The smear status,
disease severity and samples’ pre-processing may affect the results, and a further research should be warranted.
Strengths and limitations
Our study made a rigorous and comprehensive analysis and comparison about the diagnostic performance of Xpert
MTB/RIF using different sample types for PTB patients with different ages by including as many studies as possible.
Furthermore, we performed reasonable subgroup analysis to identify the source of heterogeneity and potential fac-
tors. However, the present study also has some limitations. Limited articles in the pediatric ES group and pediatric
NPA group restricted us from further analysis. Some factors including cost, the tolerance of patients and sample con-
tamination rate should be taken into consideration for final choice of diagnostics. Most included articles only used
one sample type to analyze the performance of Xpert MTB/RIF, and thus the comparison of different sample types
may be influenced by a number of potential confounding factors such as patient characteristics and the process of
sampling. Thus, more eligible trials are needed.
Conclusion
When considering diagnostic performance of Xpert MTB/RIF, sampling method and patients’ tolerance, using ES
as sample might be a better choice to diagnose adult PTB than using BAL and IS. For pediatric PTB, GA was supe-
rior to other samples. However, the invasive sampling and relatively long time of collecting samples also should be
considered. The actual choice of sample types needs to be decided according to specific situations.
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